Mark Collinge, Haley Neff-LaFord, Surekha Akella, Birgit Fogal, Kathryn Fraser, Jacob Jabbour, Kirsty Harper, Curtis C Maier, Laurent Malherbe, Nikki Marshall, Gautham K Rao, Kavita Raman, Hollie Skaggs, Felix Weber, Claudette L Fuller
Immunotoxicology/immunosafety science is rapidly evolving, with novel modalities and immuno-oncology among the primary drivers of new tools and technologies. The Immunosafety Working Group of IQ/DruSafe sought to better understand some of the key challenges in immunosafety evaluation, gaps in the science, and current limitations in methods and data interpretation. A survey was developed to provide a baseline understanding of the needs and challenges faced in immunosafety assessments, the tools currently being applied across the industry, and the impact of feedback received from regulatory agencies...
April 18, 2024: Regulatory Toxicology and Pharmacology: RTP